Yaşlılarda Sarkopeninin Tanı ve Tedavi Süreci
Referanslar
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing;2019;48(1):16–31. doi: 10.1093/ageing/afy169.
Marzetti, E., Calvani, R., Tosato, M. et al. Sarcopenia: an overview. Aging Clin Exp Res;2017; 29 ,11–17 https://doi.org/10.1007/s40520-016-0704-5.
Cho, Myung-Rae, Sungho Lee, and Suk-Kyoon Song. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. Journal of Korean medical science; 2022; 37(18): e146.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosisReport of the European Working Group on Sarcopenia in Older. Age Ageing; 2010;39(4):412-23.
Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab; 2010;35(5):707-712. doi:10.1139/H10-067
Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr); 2014;36(2):545-547. doi:10.1007/s11357-013-9583-2.
Frontera WR, Zayas AR, Rodriguez N. Aging of human muscle: understanding sarcopenia at the single muscle cell level. Phys Med Rehabil Clin N Am;2012;23(1):201–207. doi: 10.1016/j.pmr.2011.11.012.
Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol; 2013;45(10):2191–2199. doi: 10.1016/j.biocel.2013.05.016.
Edström E, Altun M, Bergman E, Johnson H, Kullberg S, Ramírez-León V, et al. Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav; 2007;92(1-2):129–135. doi: 10.1016/j.physbeh.2007.05.040.
Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol; 2018;8:1960. doi: 10.3389/fimmu.2017.01960.
Walrand S, Zangarelli A, Guillet C, Salles J, Soulier K, Giraudet C, et al. Effect of fast dietary proteins on muscle protein synthesis rate and muscle strength in ad libitum-fed and energy-restricted old rats. Br J Nutr; 2011;106(11):1683–1690. doi: 10.1017/S0007114511002182.
Huang JH, Hood DA. Age-associated mitochondrial dysfunction in skeletal muscle: Contributing factors and suggestions for long-term interventions. IUBMB Life; 2009;61(3):201–214. doi: 10.1002/iub.164.
Ferri E, Marzetti E, Calvani R, Picca A, Cesari M, Arosio B. Role of age-related mitochondrial dysfunction in sarcopenia. Int J Mol Sci; 2020;21(15):5236–5247. doi: 10.3390/ijms21155236.
Ji LL. Exercise at old age: Does it increase or alleviate oxidative stress? Ann N Y Acad Sci; 2001;928(1):236–247. doi: 10.1111/j.1749-6632.2001.tb05653.x.
Sayer, A.A., Cooper, R., Arai, H. et al. Sarcopenia. Nat Rev Dis Primers. 2024; 10, 68. https://doi.org/10.1038/s41572-024-00550-w.
Gao Q, Hu K, Yan C, et al. Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients; 2021;13(12):4291. Published 2021 Nov 27. doi:10.3390/nu13124291.
Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors; 2009;35(1):28-35. doi:10.1002/biof.5.
Landi, Francesco, et al. Protein intake and muscle health in old age: from biological plausibility to clinical evidence. Nutrients;2016; 8.5, 295.
Calvani R, Miccheli A, Landi F, et al. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging; 2013;2(1):38-53.
Martone AM, Lattanzio F, Abbatecola AM, et al. Treating sarcopenia in older and oldest old. Curr Pharm Des; 2015;21(13):1715-1722. doi:10.2174/1381612821666150130122032
Calvani R, Marini F, Cesari M, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle; 2015;6(4):278-286. doi:10.1002/jcsm.12051.
Landi F, Marzetti E, Liperoti R, et al. Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study. J Am Med Dir Assoc; 2013;14(8):626.e9-626.e6.26E13. doi:10.1016/j.jamda.2013.04.012
Marzetti E, Calvani R, Cesari M, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol; 2013;45(10):2288-2301. doi:10.1016/j.biocel.2013.06.024
Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front Aging Neurosci; 2014;6:269. doi:10.3389/fnagi.2014.00269
Landi F, Marzetti E, Martone AM, Bernabei R, Onder G. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care; 2014;17(1):25-31. doi:10.1097/MCO.0000000000000018
Bahat G, Yilmaz O, Kılıç C, Oren MM, Karan MA. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging; 2018;22(8):898–903. doi: 10.1007/s12603-018-1067-8.
Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int; 2014;14(Suppl 1):93–101. doi: 10.1111/ggi.12197.
Cooper, R. et al. Physical capability in mid-life and survival over 13 years of follow-up: British Birth Cohort Study. BMJ;2014; 348, g2219.
Koopman, J. J. et al. Handgrip strength, ageing and mortality in rural Africa. Age Ageing;2015; 44, 465–470.
Leong, D. P. et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet;2015; 386, 266–273.
Celis-Morales, C. A. et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ;2018; 361, k1651.
Bohannon, R. W. et al. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve;2012; 46, 555–558.
Roberts, H. C. et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing;2011; 40, 423–429.
Beaudart, C. et al. Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif. Tissue Int;2019; 105, 1–14.
Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985);2003;95(5):1851-1860. doi:10.1152/japplphysiol.00246.2003.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing; 2014;43(6):748-759. doi:10.1093/ageing/afu115.
Coin A, Sarti S, Ruggiero E, et al. Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. J Am Med Dir Assoc;2013;14(7):507-512. doi:10.1016/j.jamda.2013.02.010.
Landi F, Martone AM, Calvani R, Marzetti E. Sarcopenia risk screening tool: a new strategy for clinical practice. J Am Med Dir Assoc; 2014;15(9):613-614. doi:10.1016/j.jamda.2014.05.015.
Landi F, Russo A, Liperoti R, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr; 2010;29(4):441-447. doi:10.1016/j.clnu.2009.12.006.
Landi F, Onder G, Russo A, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr; 2014;33(3):539-544. doi:10.1016/j.clnu.2013.07.013.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol; 1994;49(2):M85-M94. doi:10.1093/geronj/49.2.m85.
Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci; 2008 Feb;63(2):160-4. doi: 10.1093/gerona/63.2.160. PMID: 18314451; PMCID: PMC2645663.
Cesari M. Role of gait speed in the assessment of older patients. JAMA; 2011;305(1):93-94. doi:10.1001/jama.2010.1970.
Hurst, C. et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing;2022; 51, afac003.
Shen, Y. et al. Exercise for sarcopenia in older people: a systematic review and network meta analysis. J. Cachexia Sarcopenia Muscle;2023; 14, 1199–1211.
Liu, C. J. & Latham, N. K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev; 2009; Cd002759.
Dodds, R. M. et al. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J. Cachexia Sarcopenia Muscle;2020; 11, 62–68.
Landi F., Marzetti E., Bernabei R. Perspective: Protein: What kind, how much, when? J. Am. Med. Dir. Assoc; 2013;14:66–67. doi: 10.1016/j.jamda.2012.09.020.
Kirwan, R. P. et al. Protein interventions augment the effect of resistance exercise on appendicular lean mass and handgrip strength in older adults: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr;2022; 115, 897–913.
Pinto Pereira, S. M. et al. Linear and nonlinear associations between vitamin D and grip strength: a mendelian randomization study in UK Biobank. J. Gerontol. A Biol. Sci. Med. Sci;2023; 78, 1483–1488.
Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc; 2015; 16(9):740–747. PMID: 26170041.
Yoo JI, Chung HJ, Kim BG, Jung YK, Baek KW, Song MG, et al. Comparative analysis of the association between various serum vitamin D biomarkers and sarcopenia. J Clin Lab Anal; 2021; 35(9):e23946. PMID: 34350631.
Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev; 2009;2009(3):CD002759. doi: 10.1002/14651858.CD002759.pub2
Delibaş DH, Kavakçı Ö. Sarkopeni ve Depresyon; Karşılıklı Bir İlişki Var mı? Türkiye Klinikleri Geriatrics -Special Topics; 2017;3(3):163-9.
Keskinler MV, Tufan F, Oguz A. Geriatric syndromes. Medical Journal Okmeydani Train Res Hosp; 2014;29(2):41-8.
Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism;1997;82(6):1661-7.
Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan R, Wolfe RR, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. American Physiological Society Journal; 1995; 269(1); 820- 826.
Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev; 2005;85(2):495-522.
Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol; 2007;7(6):648- 52.
Cho Y, Shin SY, Shin MJ. Sarcopenic obesity is associated with lower indicators of psychological health and quality of life in Koreans. Nutrition Research; 2015;35(5):384-92.
Miller AH, Maletic V, Raison CL. Inflammation and ıts discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry; 2009;65(9):732-41.
Van Varsseveld NC, Van Bunderen CC, Sohl E, Comijs HC, et al. Serum insulin-like growth factor 1 and late-life depression: A population-based study. Psychoneuroendocrinology; 2015;54:31-40.
Yeşil H, Eyigör S. Yaşlılarda fizik aktivite ve hastalıklara etkisi-I. Ege Tıp Dergisi; 2015;54:22- 8.
Marzetti, E., Calvani, R., Tosato, M. et al. Sarcopenia: an overview. Aging Clin Exp Res;2017; 29 ,11–17 https://doi.org/10.1007/s40520-016-0704-5.
Cho, Myung-Rae, Sungho Lee, and Suk-Kyoon Song. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. Journal of Korean medical science; 2022; 37(18): e146.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosisReport of the European Working Group on Sarcopenia in Older. Age Ageing; 2010;39(4):412-23.
Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab; 2010;35(5):707-712. doi:10.1139/H10-067
Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr); 2014;36(2):545-547. doi:10.1007/s11357-013-9583-2.
Frontera WR, Zayas AR, Rodriguez N. Aging of human muscle: understanding sarcopenia at the single muscle cell level. Phys Med Rehabil Clin N Am;2012;23(1):201–207. doi: 10.1016/j.pmr.2011.11.012.
Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol; 2013;45(10):2191–2199. doi: 10.1016/j.biocel.2013.05.016.
Edström E, Altun M, Bergman E, Johnson H, Kullberg S, Ramírez-León V, et al. Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav; 2007;92(1-2):129–135. doi: 10.1016/j.physbeh.2007.05.040.
Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol; 2018;8:1960. doi: 10.3389/fimmu.2017.01960.
Walrand S, Zangarelli A, Guillet C, Salles J, Soulier K, Giraudet C, et al. Effect of fast dietary proteins on muscle protein synthesis rate and muscle strength in ad libitum-fed and energy-restricted old rats. Br J Nutr; 2011;106(11):1683–1690. doi: 10.1017/S0007114511002182.
Huang JH, Hood DA. Age-associated mitochondrial dysfunction in skeletal muscle: Contributing factors and suggestions for long-term interventions. IUBMB Life; 2009;61(3):201–214. doi: 10.1002/iub.164.
Ferri E, Marzetti E, Calvani R, Picca A, Cesari M, Arosio B. Role of age-related mitochondrial dysfunction in sarcopenia. Int J Mol Sci; 2020;21(15):5236–5247. doi: 10.3390/ijms21155236.
Ji LL. Exercise at old age: Does it increase or alleviate oxidative stress? Ann N Y Acad Sci; 2001;928(1):236–247. doi: 10.1111/j.1749-6632.2001.tb05653.x.
Sayer, A.A., Cooper, R., Arai, H. et al. Sarcopenia. Nat Rev Dis Primers. 2024; 10, 68. https://doi.org/10.1038/s41572-024-00550-w.
Gao Q, Hu K, Yan C, et al. Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients; 2021;13(12):4291. Published 2021 Nov 27. doi:10.3390/nu13124291.
Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors; 2009;35(1):28-35. doi:10.1002/biof.5.
Landi, Francesco, et al. Protein intake and muscle health in old age: from biological plausibility to clinical evidence. Nutrients;2016; 8.5, 295.
Calvani R, Miccheli A, Landi F, et al. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging; 2013;2(1):38-53.
Martone AM, Lattanzio F, Abbatecola AM, et al. Treating sarcopenia in older and oldest old. Curr Pharm Des; 2015;21(13):1715-1722. doi:10.2174/1381612821666150130122032
Calvani R, Marini F, Cesari M, et al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle; 2015;6(4):278-286. doi:10.1002/jcsm.12051.
Landi F, Marzetti E, Liperoti R, et al. Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study. J Am Med Dir Assoc; 2013;14(8):626.e9-626.e6.26E13. doi:10.1016/j.jamda.2013.04.012
Marzetti E, Calvani R, Cesari M, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol; 2013;45(10):2288-2301. doi:10.1016/j.biocel.2013.06.024
Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip-fractured patients. Front Aging Neurosci; 2014;6:269. doi:10.3389/fnagi.2014.00269
Landi F, Marzetti E, Martone AM, Bernabei R, Onder G. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care; 2014;17(1):25-31. doi:10.1097/MCO.0000000000000018
Bahat G, Yilmaz O, Kılıç C, Oren MM, Karan MA. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging; 2018;22(8):898–903. doi: 10.1007/s12603-018-1067-8.
Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int; 2014;14(Suppl 1):93–101. doi: 10.1111/ggi.12197.
Cooper, R. et al. Physical capability in mid-life and survival over 13 years of follow-up: British Birth Cohort Study. BMJ;2014; 348, g2219.
Koopman, J. J. et al. Handgrip strength, ageing and mortality in rural Africa. Age Ageing;2015; 44, 465–470.
Leong, D. P. et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet;2015; 386, 266–273.
Celis-Morales, C. A. et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ;2018; 361, k1651.
Bohannon, R. W. et al. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve;2012; 46, 555–558.
Roberts, H. C. et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing;2011; 40, 423–429.
Beaudart, C. et al. Assessment of muscle function and physical performance in daily clinical practice: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif. Tissue Int;2019; 105, 1–14.
Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985);2003;95(5):1851-1860. doi:10.1152/japplphysiol.00246.2003.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing; 2014;43(6):748-759. doi:10.1093/ageing/afu115.
Coin A, Sarti S, Ruggiero E, et al. Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. J Am Med Dir Assoc;2013;14(7):507-512. doi:10.1016/j.jamda.2013.02.010.
Landi F, Martone AM, Calvani R, Marzetti E. Sarcopenia risk screening tool: a new strategy for clinical practice. J Am Med Dir Assoc; 2014;15(9):613-614. doi:10.1016/j.jamda.2014.05.015.
Landi F, Russo A, Liperoti R, et al. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Clin Nutr; 2010;29(4):441-447. doi:10.1016/j.clnu.2009.12.006.
Landi F, Onder G, Russo A, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr; 2014;33(3):539-544. doi:10.1016/j.clnu.2013.07.013.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol; 1994;49(2):M85-M94. doi:10.1093/geronj/49.2.m85.
Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci; 2008 Feb;63(2):160-4. doi: 10.1093/gerona/63.2.160. PMID: 18314451; PMCID: PMC2645663.
Cesari M. Role of gait speed in the assessment of older patients. JAMA; 2011;305(1):93-94. doi:10.1001/jama.2010.1970.
Hurst, C. et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing;2022; 51, afac003.
Shen, Y. et al. Exercise for sarcopenia in older people: a systematic review and network meta analysis. J. Cachexia Sarcopenia Muscle;2023; 14, 1199–1211.
Liu, C. J. & Latham, N. K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev; 2009; Cd002759.
Dodds, R. M. et al. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J. Cachexia Sarcopenia Muscle;2020; 11, 62–68.
Landi F., Marzetti E., Bernabei R. Perspective: Protein: What kind, how much, when? J. Am. Med. Dir. Assoc; 2013;14:66–67. doi: 10.1016/j.jamda.2012.09.020.
Kirwan, R. P. et al. Protein interventions augment the effect of resistance exercise on appendicular lean mass and handgrip strength in older adults: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr;2022; 115, 897–913.
Pinto Pereira, S. M. et al. Linear and nonlinear associations between vitamin D and grip strength: a mendelian randomization study in UK Biobank. J. Gerontol. A Biol. Sci. Med. Sci;2023; 78, 1483–1488.
Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc; 2015; 16(9):740–747. PMID: 26170041.
Yoo JI, Chung HJ, Kim BG, Jung YK, Baek KW, Song MG, et al. Comparative analysis of the association between various serum vitamin D biomarkers and sarcopenia. J Clin Lab Anal; 2021; 35(9):e23946. PMID: 34350631.
Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev; 2009;2009(3):CD002759. doi: 10.1002/14651858.CD002759.pub2
Delibaş DH, Kavakçı Ö. Sarkopeni ve Depresyon; Karşılıklı Bir İlişki Var mı? Türkiye Klinikleri Geriatrics -Special Topics; 2017;3(3):163-9.
Keskinler MV, Tufan F, Oguz A. Geriatric syndromes. Medical Journal Okmeydani Train Res Hosp; 2014;29(2):41-8.
Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism;1997;82(6):1661-7.
Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan R, Wolfe RR, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. American Physiological Society Journal; 1995; 269(1); 820- 826.
Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev; 2005;85(2):495-522.
Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol; 2007;7(6):648- 52.
Cho Y, Shin SY, Shin MJ. Sarcopenic obesity is associated with lower indicators of psychological health and quality of life in Koreans. Nutrition Research; 2015;35(5):384-92.
Miller AH, Maletic V, Raison CL. Inflammation and ıts discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry; 2009;65(9):732-41.
Van Varsseveld NC, Van Bunderen CC, Sohl E, Comijs HC, et al. Serum insulin-like growth factor 1 and late-life depression: A population-based study. Psychoneuroendocrinology; 2015;54:31-40.
Yeşil H, Eyigör S. Yaşlılarda fizik aktivite ve hastalıklara etkisi-I. Ege Tıp Dergisi; 2015;54:22- 8.
Sayfalar
47-60
Gelecek
13 Şubat 2025
Telif Hakkı (c) 2025 Akademisyen Yayınevi Kitap DOI Portalı
